Antiva Biosciences is a clinical-stage biopharmaceutical company developing topical therapeutics that target oncogenic human papillomavirus (HPV) infections and the precancerous cervical lesions they cause, aiming to stop cervical cancer before it starts with at-home, non-surgical treatment. - View it on GitHub